Abstract
Glaucoma is a chronic neurodegenerative disease characterized by progressive loss of retinal ganglion cells and optic nerve axons, and accompanying loss of visual field sensitivity. With the development of immunology, compelling evidence obtained suggests the involvement of immune system regulation in glaucomatous optic nerve degeneration. Despite the neuroprotective features of immune system, an autoimmune component resulting from a failure to properly control aberrant and stress-induced immune response likely lead to the progression of neurodegeneration in glaucoma. A better understanding of the diverse roles of the immune system in all forms of glaucomatous optic nerve degeneration will facilitate the development of effective neuroprotective strategies in glaucoma. The effect of immune system on glaucomatous neuropathy is reviewed in this article.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
